Recent developments in the ability to predict and modify breast cancer risk.

Area of Science:

• Oncology
• Public Health
• Plastic Surgery

Background:

• Accurate identification of women at high risk for breast cancer is a significant public health concern.
• Plastic surgeons must be aware of predictive models and risk assessment tools for breast cancer.
• Traditional breast cancer screening relied on mammography timing; newer risk prediction methods require understanding.

Purpose of the Study:

• To review current knowledge on breast cancer risk, screening for high-risk women, and risk-reduction strategies.
• To inform the specialty of plastic surgery about advancements in breast cancer risk prediction and management.
• To highlight the importance of identifying women at higher risk for breast cancer.

Main Methods:

• Review of current literature on breast cancer risk.
• Discussion of various breast cancer risk assessment tools (e.g., Gail model, Claus model, BRCAPRO, genetic screening).
• Categorization of breast cancer into sporadic, genetic mutation (BRCA1/BRCA2), and familial clusters.

Main Results:

• Breast cancer is categorized into sporadic (75%), genetic mutation (5%), and cluster family (20%) types.
• High-risk individuals should undergo evaluation of family history, clinical history, and mammographic density.
• Various tools exist for assessing breast cancer risk, including genetic testing and predictive models.

Conclusions:

• Understanding breast cancer risk factors and assessment tools is essential for plastic surgeons and public health.
• Effective screening and risk-reduction strategies are vital for managing high-risk women.
• Multifaceted approaches including genetic counseling and risk assessment models improve breast cancer risk identification.